Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MLTX | BBOT | VIR | ||
| Company | Moonlake Immunotherapeutics | Bridgebio Oncology Therapeutics Inc | Vir Biotechnology Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 14.79 | 12.48 | 6.77 | ||
| High | 14.79 | 12.73 | 6.97 | ||
| Low | 14.29 | 11.81 | 6.69 | ||
| Latest | 14.32 | 12.00 | 6.72 | ||
| Change | -0.47 | -0.59 | +0.03 | ||
| % Change | -3.18% | -4.69% | +0.45% | ||
| Volume | 1,360,200 | 124,200 | 1,267,000 | ||
| 20-Day Average Volume | 2,015,950 | 178,275 | 1,825,575 | ||
| Previous Close | 14.79 | 12.59 | 6.69 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 13.82 | 12.47 | 6.21 | ||
| 20-Day Raw Stochastic | 60.48% | 31.50% | 80.46% | ||
| 20-Day Relative Strength | 46.18 | 48.70 | 59.09 | ||
| Weighted Alpha | +88.58 | +12.51 | -17.24 | ||
| Today's Opinion | 40% Sell | 64% Buy | 88% Buy | ||
| Previous Opinion | 40% Sell | 96% Buy | 88% Buy | ||
| Last Month's Opinion | 88% Sell | 100% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.98% since 12/08/25 | -8.68% since 12/08/25 | +2.13% since 12/08/25 | ||
| Low | 13.87 on 12/11/25 | 11.81 on 12/15/25 | 6.49 on 12/10/25 | ||
| High | 15.05 on 12/09/25 | 13.58 on 12/11/25 | 6.97 on 12/15/25 | ||
| 1-Month | |||||
| %Chg | +12.14% since 11/14/25 | -8.54% since 11/14/25 | +19.36% since 11/14/25 | ||
| Low | 12.43 on 11/21/25 | 10.68 on 12/03/25 | 5.32 on 11/19/25 | ||
| High | 15.56 on 12/08/25 | 14.87 on 12/08/25 | 7.06 on 12/08/25 | ||
| 3-Month | |||||
| %Chg | -73.12% since 09/15/25 | +23.33% since 09/15/25 | +40.29% since 09/15/25 | ||
| Low | 5.95 on 09/29/25 | 9.61 on 09/16/25 | 4.75 on 09/16/25 | ||
| High | 62.75 on 09/26/25 | 14.87 on 12/08/25 | 7.06 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | -67.61% since 06/13/25 | +10.80% since 06/13/25 | +28.74% since 06/13/25 | ||
| Low | 5.95 on 09/29/25 | 8.50 on 08/05/25 | 4.16 on 08/11/25 | ||
| High | 62.75 on 09/26/25 | 14.87 on 12/08/25 | 7.06 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 949,977 | 1,007,061 | 930,746 | ||
| Shares Outstanding, K | 64,231 | 79,989 | 139,125 | ||
| Annual Sales | 0 | 0 | 74,210,000 | ||
| Annual Net Income | -118,940,000 | -74,275,000 | -521,960,000 | ||
| Last Quarter Sales | 0 | 0 | 240,000 | ||
| Last Quarter Net Income | -69,730,000 | -44,757,000 | -163,140,000 | ||
| 60-Month Beta | 1.21 | 0.13 | 1.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.10 on 11/05/25 | -1.03 on 11/12/25 | -1.17 on 11/05/25 | ||
| Latest Earnings Date | 02/25/26 | 02/11/26 | 02/25/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||